Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1806
TNBC
Basal A
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7451.067
uM
3.85010
6.87260
-0.8258 -0.8561 1.7219 0.4693
0.9990
2.0570
HCC1806
TNBC
Basal A
TAPI-0
TACE/Collagenase
7451.096
uM
inf
3.8750
0.7347 0.6534 0.5656 0.0770
0.9490
2.1851
HCC1806
TNBC
Basal A
Taxol
TUBB
TUBB
9376.002
uM
0.00736
0.01035
-0.5241 -0.4275 1.8127 0.8756
0.9937
1.5057
HCC1806
TNBC
Basal A
Taxol
TUBB
TUBB
7829.002
uM
0.00654
0.00859
-0.6554 -0.5946 2.8793 1.0258
0.9950
1.8681
HCC1806
TNBC
Basal A
Taxol
TUBB
TUBB
12702.002
uM
0.00503
0.00695
-0.5565 -0.5283 2.2293 1.0058
0.9990
1.8712
HCC1806
TNBC
Basal A
TCS 2312
CHK1
CHK
12239.152
uM
0.63654
0.88180
-0.6688 -0.6355 2.5166 0.4858
0.9954
2.2104
HCC1806
TNBC
Basal A
TCS PIM-1 1
Pim kinase
PIM
12239.135
uM
inf
139.88920
0.8108 0.5708 4.7176 -0.0202
0.7417
2.0860
HCC1806
TNBC
Basal A
Temsirolimus
MTOR
MTOR
12239.144
uM
28.59970
54.3170
-0.6680 -1.0000 1.7127 0.2315
0.9575
2.1598
HCC1806
TNBC
Basal A
Topotecan
TOP1
TOP
9376.121
uM
0.02208
0.07165
-0.8690 -0.8510 0.8445 1.0381
0.9964
1.3803
HCC1806
TNBC
Basal A
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12239.16
uM
18.690
37.25160
0.0878 -1.0000 1.5929 0.0829
0.9812
1.8654
HCC1806
TNBC
Basal A
TPCA-1
IKK
NFKB
7451.093
uM
inf
2.46790
0.5184 0.5041 1.4693 0.1472
0.9736
2.1935
HCC1806
TNBC
Basal A
Trametinib
MEK
MAPK
7829.036
uM
inf
0.00253
0.5231 0.5314 1.2413 0.3159
0.9745
1.9542
HCC1806
TNBC
Basal A
Trametinib
MEK
MAPK
9376.024
uM
inf
0.00202
0.6940 0.6946 3.4269 0.2081
0.9818
1.7329
HCC1806
TNBC
Basal A
Trastuzumab
HER2
ErbB
9376.026
uM
inf
inf
0.9395 0.9395 0.0000 -0.0232
0.0979
1.6827
HCC1806
TNBC
Basal A
Trichostatin A
HDAC
HDAC
7451.065
uM
10.10380
14.65910
-0.7397 -0.7271 2.4126 0.7962
0.9982
2.1525
HCC1806
TNBC
Basal A
Trichostatin A
HDAC
HDAC
7450.065
uM
13.14030
20.61310
-0.6278 -0.6243 1.7996 0.7072
0.9983
2.4231
HCC1806
TNBC
Basal A
Triciribine
AKT
AKT
7450.074
uM
0.07746
0.17066
-0.4285 -0.3470 0.6672 0.5284
0.9782
2.2338
HCC1806
TNBC
Basal A
Triciribine
AKT
AKT
7451.074
uM
1.06430
12.69480
0.0309 -0.6620 0.3402 0.3257
0.9971
2.1799
HCC1806
TNBC
Basal A
Valproic acid
HDAC
HDAC
12239.143
uM
859.64440
1000.00000
-0.4116 -0.0836 1.0222 0.2392
0.7203
2.1267
HCC1806
TNBC
Basal A
Vinorelbine
TUBB
TUBB
7829.042
uM
0.00562
0.00686
-0.7934 -0.5149 3.5540 1.0274
0.9752
1.8673
HCC1806
TNBC
Basal A
Vinorelbine
TUBB
TUBB
7830.018
uM
0.0220
0.02315
-0.0933 -0.1447 5.0000 0.6445
0.9806
1.5320
HCC1806
TNBC
Basal A
Vorinostat
HDAC
HDAC
7450.065
uM
181.52970
394.91930
-0.6252 -0.6847 1.1098 0.5145
0.9954
2.4231
HCC1806
TNBC
Basal A
Vorinostat
HDAC
HDAC
7451.065
uM
153.05320
257.03860
-0.7378 -0.7473 1.7633 0.5991
0.9967
2.1525
HCC1806
TNBC
Basal A
XRP44X
ELK3
MAPK
12239.157
uM
1.14210
1.21950
-0.2021 -0.1937 4.9993 0.4166
0.9965
2.0946
HCC1806
TNBC
Basal A
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14128.189
uM
1.43790
2.14480
-0.5853 -0.5895 1.9480 0.4731
0.9881
2.7793